Related Experiment Video
Updated: May 2, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
[Recent advances in the diagnosis and treatment of childhood tuberculosis]
Jia-Hua Pan1, Jia-Hua Pan, Xue Zhang
1Department of Pediatrics, Anhui Provincial Hospital, Anhui Medical University, Hefei 230001, China. panjiahua1960@163.com.
Insights
Tuberculosis (TB) diagnosis and treatment in children are challenging due to atypical symptoms and drug resistance. This review covers recent advances in TB epidemiology, diagnostics, and pediatric treatment strategies.
Area of Science:
- Infectious Diseases
- Pediatric Medicine
- Microbiology
Context:
- Tuberculosis (TB) poses significant global health challenges, particularly in pediatric populations.
- Atypical clinical presentations complicate early and accurate diagnosis of TB in children.
- The rise of multidrug-resistant TB (MDR-TB) further exacerbates treatment difficulties in pediatric cases.
Purpose:
- To provide a comprehensive review of recent research on tuberculosis.
- To detail advances in understanding TB epidemiology and clinical manifestations.
- To evaluate current and emerging diagnostic and therapeutic strategies for pediatric TB.
Summary:
- This review synthesizes current literature on tuberculosis, focusing on epidemiology, clinical features, and diagnostic methods like skin tests, imaging, and lab analyses.
- It specifically addresses the complexities of diagnosing and treating tuberculosis in children, including challenges posed by multidrug-resistant strains.
- The paper highlights recent research advancements across these critical areas of pediatric TB.
Impact:
- Enhances understanding of tuberculosis in children, aiding clinicians and researchers.
- Identifies gaps in current diagnostic and treatment protocols for pediatric TB.
- Informs the development of improved screening, diagnostic, and therapeutic interventions for childhood tuberculosis.
Abstract:
Tuberculosis (TB) is a chronic infectious disease that seriously harms human health and wellbeing. Given its atypical clinical manifestations, TB is hard to be diagnosed in clinical settings; to date no highly sensitive screening approaches are available. Due to the emergence of multidrug-resistant strains of TB (MDR-TB) and limited options for medications in children, the treatment of TB is even more challenging in pediatric patients. This paper aims to comprehensively review the literature on the recent advances in the research on the epidemiology and clinical manifestations of TB, on TB diagnostic approaches (e.g., tuberculin skin test, imaging studies, and laboratory tests), and on TB treatment in children.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Other Pulmonary Disorders